Back to search

Article

Fully Quantitative Measurements of Differential Antibody Binding to a Spectrum of SARS-CoV-2 Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4, BA.5, BA.2.75 and BA.2.12.1

2023-01-11

Abstract excerpt

A fully quantitative comparative analysis has been performed on the differential antibody binding to a spectrum of Spike proteins to the SARS-CoV-2 variants Wuhan, Alpha, Beta, Gamma, Delta and Omicron BA.1, BA.1, BA.4, BA.5, BA.2.75 and BA.2.12.1. The immunity profile was determined for four patient cohorts: pre-pandemic, the first infection in the pandemic, Wuhan(+), and two vaccinated cohorts, the initial doubl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c085be9b-efd4-5b86-b45d-f690c3b919b8
DOI
10.1101/2023.01.11.23284431
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fully Quantitative Measurements of Differential Antibody Binding to a Spectrum of SARS-CoV-2 Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4, BA.5, BA.2.75 and BA.2.12.1DOI 10.1101/2023.01.11.23284431
Mass-Standardised Differential Antibody Binding to a Spectrum of SARS-CoV-2 Variant Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4/5, BA.2.75 and BA.2.12.1 variants - Antibody Immunity EndotypesSemantic proximity
Mass-Standardised Quantitative Measurements of the Antibody Levels for SARS-CoV-2 beyond Correlates of Protection and ClearanceSemantic proximity
SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunitySemantic proximity
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody responseSemantic proximity
Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.Semantic proximity
Anti-spike antibody response to natural infection with SARS-CoV-2 and its activity against emerging variantsSemantic proximity
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine doseSemantic proximity
Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody featuresSemantic proximity
Antibody avidity and neutralizing response against SARS-CoV-2 Omicron variant after infection or vaccinationSemantic proximity
Infection and vaccine induced Spike antibody responses against SARS-CoV-2 Variants of concern in immune naïve children and adultsSemantic proximity
High individual heterogeneity of neutralizing activities against the original 4 strain and 9 different variants of SARS-CoV-2Semantic proximity
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinationsSemantic proximity
Select a neighboring publication to make it the new centre.